共查询到20条相似文献,搜索用时 15 毫秒
1.
2.
TIMIR S. BAMAN M.D. SANJAYA K. GUPTA M.D. SREEDHAR R. BILLAKANTY M.D. KARL J. ILG M.D. ERIC GOOD D.O. THOMAS CRAWFORD M.D. KRIT JONGNARANGSIN M.D. MATT EBINGER D.O. FRANK PELOSI
Jr
M.D. FRANK BOGUN M.D. AMAN CHUGH M.D. FRED MORADY M.D. HAKAN ORAL M.D. 《Journal of cardiovascular electrophysiology》2009,20(12):1321-1325
Introduction: It is unclear whether early restoration of sinus rhythm in patients with persistent atrial arrhythmias after catheter ablation of atrial fibrillation (AF) facilitates reverse atrial remodeling and promotes long‐term maintenance of sinus rhythm. The purpose of this study was to determine the relationship between the time to restoration of sinus rhythm after a recurrence of an atrial arrhythmia and long‐term maintenance of sinus rhythm after radiofrequency catheter ablation of AF. Methods and Results: Radiofrequency catheter ablation was performed in 384 consecutive patients (age 60 ± 9 years) for paroxysmal (215 patients) or persistent AF (169 patients). Transthoracic cardioversion was performed in all 93 patients (24%) who presented with a persistent atrial arrhythmia: AF (n = 74) or atrial flutter (n = 19) at a mean of 51 ± 53 days from the recurrence of atrial arrhythmia and 88 ± 72 days from the ablation procedure. At a mean of 16 ± 10 months after the ablation procedure, 25 of 93 patients (27%) who underwent cardioversion were in sinus rhythm without antiarrhythmic therapy. Among the 46 patients who underwent cardioversion at ≤30 days after the recurrence, 23 (50%) were in sinus rhythm without antiarrhythmic therapy. On multivariate analysis of clinical variables, time to cardioversion within 30 days after the onset of atrial arrhythmia was the only independent predictor of maintenance of sinus rhythm in the absence of antiarrhythmic drug therapy after a single ablation procedure (OR 22.5; 95% CI 4.87–103.88, P < 0.001). Conclusion: Freedom from AF/flutter is achieved in approximately 50% of patients who undergo cardioversion within 30 days of a persistent atrial arrhythmia after catheter ablation of AF. 相似文献
3.
4.
KARUNA CHILUKURI DARSHAN DALAL SHRIRANG GADREY JOSEPH E. MARINE EDWIN MACPHERSON CHARLES A. HENRIKSON ALAN CHENG SAMAN NAZARIAN SUNIL SINHA DAVID SPRAGG RONALD BERGER HUGH CALKINS 《Journal of cardiovascular electrophysiology》2010,21(5):521-525
Effect of Obesity and OSA on Outcomes Post AF Ablation . Background: Obesity and obstructive sleep apnea (OSA) have a strong association with atrial fibrillation (AF). The purpose of this study was to prospectively determine the effects of obesity, assessed by the body mass index (BMI) and OSA on the efficacy of catheter ablation of AF. Methods: The patient population consisted of 109 patients (mean age: 60 ± 10 years, 79% male, 67% paroxysmal, mean BMI 28 ± 5 kg/m2) who underwent catheter ablation of AF. Based on BMI, patients were classified as normal (<25 kg/m2), overweight (≥25 and <30 kg/m2), or obese (≥30 kg/m2). OSA was assessed by the Berlin questionnaire. Clinical success was defined as at least 90% reduction in AF burden after 3‐month blanking period. Mean duration of follow‐up was 11 ± 4 months. Results: Of the 75 patients with clinical success, 25 (33%) had normal BMI, 29 (39%) were overweight, and 21 (28%) were obese. Among the 34 patients with failed outcome, 5 (15%) had normal BMI, 14 (41%) were overweight, and 15 (44%) were obese (P = 0.04). Twenty‐eight of the 48 patients with OSA (58%) had clinical success as opposed to 47 of the 61 patients (77%) without OSA (P = 0.036). On multivariate analysis, only BMI emerged as an independent predictor of procedural failure ((OR 1.11, CI: 1.00–1.21, P = 0.03). Conclusions: The results of this prospective study show that obesity, a modifiable risk factor, is an independent predictor of procedural failure after catheter ablation of AF. Whether treating obesity may improve the results of catheter ablation of AF warrants further investigation. (J Cardiovasc Electrophysiol, Vol. 21, pp. 521‐525, May 2010) 相似文献
5.
ANITA WOKHLU M.D. DAVID O. HODGE M.S. KRISTI H. MONAHAN R.N. SAMUEL J. ASIRVATHAM M.D. PAUL A. FRIEDMAN M.D. THOMAS M. MUNGER M.D. YONG‐MEI CHA M.D. WIN‐KUANG SHEN M.D. PETER A. BRADY M.D. CHRISTINE M. BLUHM R.N. JANIS M. HAROLDSON R.N. STEPHEN C. HAMMILL M.D. DOUGLAS L. PACKER M.D. 《Journal of cardiovascular electrophysiology》2010,21(10):1071-1078
Long‐Term Outcome of AF Ablation. Introduction: Ablation eliminates atrial fibrillation (AF) in studies with 1 year follow‐up, but very late recurrences may compromise long‐term efficacy. In a large cohort, we sought to describe the determinants of delayed recurrence after AF ablation. Methods and Results: Seven hundred and seventy‐four patients with AF (428 paroxysmal [PAF, 55%] and 346 persistent or longstanding persistent [PersAF, 45%]) underwent wide area circumferential ablation (WACA, 62%) or pulmonary vein isolation (38%). Over 3.0 ± 1.9 years, there were 135 recurrences in PAF patients and 142 in PersAF patients. AF elimination was achieved in 61% of patients with PersAF at 2 years after last ablation and in 71% of patients with PAF (P = 0.04). This finding was related to a higher initial rate of very late recurrence in PersAF. From 1.0 to 2.5 years, the recurrence increased by 20% (from 37% to 57%) in PersAF patients versus only 12% (from 27% to 39%) in PAF patients. Independent predictors of overall recurrence included diabetes (HR 1.9 [1.3–2.9], P = 0.002) and PersAF (HR 1.6 [1.2–2.0], P < 0.001). Independent predictors of very late recurrence included PersAF (HR 1.7 [1.1–2.7], P = 0.018) and WACA (HR 1.8 [1.1–2.7], P = 0.018), while diabetes came close to significance. In PAF patients, left atrial size >45 mm was identified as an AF‐type specific predictor (HR 2.4 [1.3–4.7], P = 0.009), whereas in PersAF patients, no unique predictors were identified. Conclusion: Late recurrences reduced the long‐term efficacy of AF ablation, particularly in patients with PersAF and underlying cardiovascular diseases. (J Cardiovasc Electrophysiol, Vol. 21, pp. 1071‐1078) 相似文献
6.
Electrophysiologic Findings and Long‐Term Outcomes in Patients Undergoing Third or More Catheter Ablation Procedures for Atrial Fibrillation 下载免费PDF全文
DAVID LIN M.D. PASQUALE SANTANGELI M.D. ERICA S. ZADO P.A.C. RUPA BALA M.D. MATHEW D. HUTCHINSON M.D. MICHAEL P. RILEY M.D. Ph.D. DAVID S. FRANKEL M.D. FERMIN GARCIA M.D. SANJAY DIXIT M.D. DAVID J. CALLANS M.D. FRANCIS E. MARCHLINSKI M.D. 《Journal of cardiovascular electrophysiology》2015,26(4):371-377
7.
HUNG‐YU CHANG M.D. LI‐WEI LO M.D. YENN‐JIANG LIN M.D. SHIH‐LIN CHANG M.D. YU‐FENG HU M.D. CHENG‐HUNG LI M.D. TZE‐FAN CHAO M.D. FA‐PO CHUNG M.D. TRUNG LE HA M.D. RAHUL SINGHAL M.D. ERIC CHONG M.D. WEI‐HSIAN YIN M.D. HSUAN‐MING TSAO M.D. MING‐HSIUNG HSIEH M.D. SHIH‐ANN CHEN M.D. 《Journal of cardiovascular electrophysiology》2013,24(3):250-258
Long‐Term Outcome of NPV AF Ablation . Introduction: Data regarding the long‐term outcome of catheter ablation in patients with nonpulmonary vein (NPV) ectopy initiating atrial fibrillation (AF) are limited. We aimed to evaluate the long‐term result of patients with AF who had NPV triggers and underwent catheter ablation. Methods and Results: The study included 660 consecutive patients (age 54 ± 11 years old, 477 males) who had undergone catheter ablation for AF. Group 1 consisted of 132 patients with AF initiating from the NPV, and group 2 consisted of 528 patients with AF initiating from pulmonary vein (PV) triggers only. Patients from Group 1 were younger than those from Group 2 (51 ± 12 years old vs 54 ± 11 years old, P = 0.001) and were more likely to be females (34.4% vs 25.8%, P = 0.049). The incidences of nonparoxysmal AF (36.4% vs 16.3%, P < 0.001) and right atrial (RA) enlargement (31.3% vs 19%, P = 0.004) were higher, and the biatrial substrates were worse in Group 1 than those in Group 2 (left atrial voltage 1.5 ± 0.7 mV vs 1.9 ± 0.7 mV, P < 0.001, RA voltage 1.6 ± 0.5 mV vs 1.8 ± 0.6 mV, P = 0.014). During a follow‐up period of 46 ± 23 months, there was a higher AF recurrence rate in Group 1 than in Group 2 (57.6% vs 38.8%, P < 0.001). The independent predictors of AF recurrence were NPV trigger (P < 0.001, HR 2, 95% CI 1.4–2.85), nonparoxysmal AF (P = 0.021, HR 1.55, 95% CI 1.07–2.24), larger left atrial diameter (P = 0.002, HR 1.04, 95% CI 1.02–1.07) and worse left atrial substrate (P = 0.028, HR 1.3, 95% CI 1.03–1.64). Conclusion: Compared to AF originating from the PV alone, AF originating from the NPV ectopy showed a worse outcome. (J Cardiovasc Electrophysiol, Vol. 24, pp. 250‐258, March 2013) 相似文献
8.
Long‐Term Outcome of Left Atrial Voltage‐Guided Substrate Ablation During Atrial Fibrillation: A Novel Adjunctive Ablation Strategy 下载免费PDF全文
ATSUHIKO YAGISHITA M.D. J. ROD GIMBEL M.D. SAMER DE OLIVEIRA M.D. HARISH MANYAM M.D. DINA SPARANO M.D. IVAN CAKULEV M.D. JUDITH MACKALL M.D. MAURICIO ARRUDA M.D. 《Journal of cardiovascular electrophysiology》2017,28(2):147-155
9.
10.
ANTONIO NAVARRETE M.D. FRANK CONTE M.D. MICHAEL MORAN M.D. ISHTI ALI M.D. NATHAN MILIKAN M.D. 《Journal of cardiovascular electrophysiology》2011,22(1):34-38
AF Ablation in Patients With Only Documentation of Atrial Flutter. Objectives: The aim of the study was to evaluate whether isolation of the pulmonary veins (PVs) at the time of cavotricuspid isthmus (CTI) ablation is beneficial in patients with lone atrial flutter (AFL). Background: A high proportion of patients with lone persistent AFL have recurrent episodes of atrial fibrillation (AF) after CTI ablation. However, the benefit of AF ablation in patients with only documentation of AFL has not been determined. Methods: Forty‐eight patients with typical lone persistent AFL (age 56 ± 6; 90% male) were randomized to CTI ablation (Group A; n = 25) or to CTI + PV isolation (PVI) (Group B; n = 23). In addition to PVI, some patients in group B underwent ablation of complex fractionated electrograms and/or creation of left atrial roof and mitral isthmus ablation line in a stepwise approach when AF was induced and sustained for more than 2 minutes. Mean follow‐up was 16 ± 4 months with a 48‐hour ambulatory monitor every 2 months. Results: There were no recurrences of AFL in either group. Six patients in group B (22%) underwent a stepwise ablation protocol. AF organized and terminated in 5 patients during ablation (83%). Complication rate was not significantly different among the groups. Twenty patients in group B (87%) and 11 patients in group A (44%) were free of arrhythmias on no medications at the end of follow‐up (P < 0.05). Conclusions: Ablation of AF at the time of CTI ablation results in a significantly better long‐term freedom from arrhythmias. (J Cardiovasc Electrophysiol, Vol. 22, pp. 34‐38, January 2011) 相似文献
11.
12.
13.
SHINSUKE MIYAZAKI M.D. TAISHI KUWAHARA M.D. ATSUSHI KOBORI M.D. YOSHIHIDE TAKAHASHI M.D. ASUMI TAKEI M.D. AKIRA SATO M.D. MITSUAKI ISOBE M.D. ATSUSHI TAKAHASHI M.D. 《Journal of cardiovascular electrophysiology》2010,21(11):1193-1198
AF Ablation in Patients With Valvular Heart Disease . Background: The purpose of this study is to evaluate the efficacy of atrial fibrillation (AF) ablation in patients with moderate valvular heart disease (VHD). Methods: In total, 534 consecutive patients who underwent AF ablation were enrolled. Patients with a history of valve surgery or other structural heart disease were excluded. Patients with clinically moderate VHD (group‐1, n = 45) were compared with those without VHD (control group‐2, n = 436). Ipsilateral pulmonary vein antrum isolation (PVAI) was performed with a double Lasso technique in all the patients. Left atrial (LA) linear ablation was undertaken in persistent AF patients, if AF was inducible after PVAI. Results: Patients in group‐1 were significantly older and had a larger LA. PVAI was successfully achieved in all the patients. Patients in group‐1 received LA linear ablation more frequently during the index procedure. After a median of 26 months from the index procedure, the freedom from AF was significantly lower in group‐1 than group‐2 off antiarrhythmic drugs (AADs) (47% vs 69%, P = 0.002). Although there were more number of total procedures in group‐1 than group‐2, the freedom from AF was lower at median 24 months after the last procedure (78% vs 87%, P = 0.038). There was no significant difference in the freedom from AF on AADs (91% vs 95%, P = 0.356) or complication rate between the 2 groups. Atrial tachycardia following the index procedure was observed more frequently in group‐1 (P = 0.001). Conclusion: The patients with VHD undergoing AF ablation are less likely to remain in sinus rhythm at long term without AADs than those without VHD. (J Cardiovasc Electrophysiol, Vol. 21, pp. 1193‐1198, November 2010) 相似文献
14.
RONG BAI M.D. F.H.R.S. F.E.S.C. LUIGI DI BIASE M.D. Ph.D. F.H.R.S. PRASANT MOHANTY M.B.B.S. M.P.H. PASQUALE SANTANGELI M.D. SANGHAMITRA MOHANTY M.D. AGNES PUMP M.D. CLAUDE S. ELAYI M.D. YERUVA MADHU REDDY M.D. GIOVANNI B. FORLEO M.D. RICHARD HONGO M.D. SALWA BEHEIRY R.N. ANTONIO DELLO RUSSO M.D. MICHELA CASELLA M.D. GEMMA PELARGONIO M.D. PIETRO SANTARELLI M.D. RODNEY HORTON M.D. JAVIER SANCHEZ M.D. JOSEPH GALLINGHOUSE M.D. J. DAVID BURKHARDT M.D. F.H.R.S. CHANGSHENG MA M.D. DHANUNJAYA LAKKIREDDY M.D. F.A.C.C. F.H.R.S. CLAUDIO TONDO M.D. ANDREA NATALE M.D. F.H.R.S. 《Journal of cardiovascular electrophysiology》2014,25(8):824-833
15.
ANDREW W. TEH M.B.B.S. CAROLINE MEDI
B.Med. RAPHAEL ROSSO M.D. GEOFFREY LEE
M.B.Ch.B. KAREN HALLORAN R.N. JITENDRA K. VOHRA M.D. 《Journal of cardiovascular electrophysiology》2010,21(7):747-750
Atrial Fibrillation and Pulmonary Vein Tachycardia . Objectives: This study aimed to characterize the long‐term outcome and incidence of atrial fibrillation (AF) in patients following catheter ablation of focal atrial tachycardia (AT) from the pulmonary veins (PV). Background: Although both AT and AF may originate from ectopic foci within PVs, it is unknown whether PV AT patients subsequently develop AF. Methods: Twenty‐eight patients with 29 PV ATs (14%) from a consecutive series of 194 patients who underwent RFA for focal AT were included. Patients with concomitant AF prior to the index procedure were excluded. Results: The minimum follow‐up duration was 4 years; mean age 38 ± 18 years with symptoms for 6.5 ± 10 years, having tried 1.5 ± 0.9 antiarrhythmic drugs. The distribution of foci was: left superior 12 (41%), right superior 10 (34%), left inferior 5 (17%), and right inferior 2 (7%). The focus was ostial in 93% and 2–4 cm distally within the vein in 7%. Mean tachycardia cycle length was 364 ± 90 ms. Focal ablation was performed in 25 of 28 patients. There were 6 recurrences with 5 from the original site. Twenty‐six patients were available for long‐term clinical follow‐up. At a mean of 7.2 ± 2.1 years, 25 of 26 (96%) were free from recurrence off antiarrhythmic drugs. No patients developed AF. Conclusions: Focal ablation for tachycardia originating from the PVs is associated with long‐term freedom from both AT and AF. Therefore, although PV AT and PV AF share a common anatomic distribution, PV AT is a distinct clinical entity successfully treated with focal RFA and not associated with AF in the long term. (J Cardiovasc Electrophysiol, Vol. pp. 747‐750, July 2010) 相似文献
16.
17.
Right Atrial Compartmentalization Using Radiofrequency Catheter Ablation for Management of Patients with Refractory Atrial Fibrillation 总被引:1,自引:0,他引:1
ASHOK GARG M.D. WILLIAM FINNERAN M.D. MICHAEL MOLLERUS M.D. ULRIKA BIRGERSDOTTER-GREEN M.D. OSAMU FUJIMURA M.D. LINDA TONE R.N. GREGORY K. FELD M.D. 《Journal of cardiovascular electrophysiology》1999,10(6):763-771
INTRODUCTION: Atrial fibrillation (AF) is often refractory to antiarrhythmic drugs, and patients who are intolerant of AF may require the maze operation for cure. As a less invasive alternative, a catheter-based, right atrial compartmentalization procedure was evaluated. METHODS AND RESULTS: Twelve patients with AF refractory to Class I and III antiarrhythmic drugs were studied. Four linear right atrial radiofrequency ablations were performed, from superior to inferior vena cava in the posterior wall and interatrial septum, anteriorly from the superior vena cava to the tricuspid annulus through the appendage, and across the tricuspid valve-inferior vena cava isthmus. The radiofrequency catheter was dragged along each line three to four times, until the atrial electrogram amplitude decreased by 75% and there was bidirectional conduction block in the tricuspid valve-inferior vena cava isthmus. One complication occurred: sinus node dysfunction requiring a pacemaker. Eight patients were discharged from the hospital on no antiarrhythmic drugs, and four were discharged on previously ineffective antiarrhythmic drugs. Total duration of follow-up was 21.3 +/- 11.2 months. Four patients discharged on previously ineffective antiarrhythmic drugs had no recurrence of AF. One patient discharged off antiarrhythmic drugs had no recurrence of AF. Seven patients discharged off antiarrhythmic drugs had recurrent AF by 12.6 +/- 13.0 months (median 6, range 1 to 39); 3 of these 7 responded to previously ineffective antiarrhythmic drugs without further AF and 4 did not. Thus, 8 of 12 patients (67%) had suppression of AF after ablation on previously ineffective medication or no medication. CONCLUSION: Right atrial compartmentalization may alter the substrate for AF, thus improving the efficacy of previously ineffective antiarrhythmic drugs. Because it is relatively safe, it may be a reasonable adjunctive intervention to maintain sinus rhythm in patients with drug-refractory AF. 相似文献
18.
19.
20.
MICHEL HAÏSSAGUERRE M.D. FRANK I. MARCUS M.D. BRUNO FISCHER M.D. JACQUES CLÉMENTY M.D. 《Journal of cardiovascular electrophysiology》1994,5(9):743-751
RF Catheter Ablation in AF. Introduction: The purpose of this study was to test the feasibility of radiofrequency (RF) catheter ablation of localized mechanisms of atrial fibrillation (AF).
Methods and Results: Three patients underwent RF catheter ablation for drug-resistant atrial arrhythmias. The first two patients had either incessant atrial tachycardia or AF. In the first patient, the KCG pattern of AF was mimicked by a very rapid atrial focus, whereas in the second patient, AF was due to true degeneration of the atrial activity triggered by atrial tachycardia. In both patients, the ablation of atrial focus led to the clinical disappearance of AF. The third patient had frequent episodes of AF, which lasted several days or weeks, and two documented episodes of atrial flutter. Mapping during AF showed an irregular atrial rhythm in the atrial septum, particularly in the region surrounding the coronary sinus, whereas the entire lateral right atrial free wall exhibited a constantly organized rhythm. RF energy was applied between the tricuspid ring and both the inferior vena cava and the coronary sinus, resulting in inability to reinduceatrial flutter or sustained AF. A 6-month follow-up in this patient showed the disappearance of prolonged episodes of AF.
Conclusion: The observations indicate that AF may be linked to "focal" mechanisms that can be treated by RF catheter ablation. 相似文献
Methods and Results: Three patients underwent RF catheter ablation for drug-resistant atrial arrhythmias. The first two patients had either incessant atrial tachycardia or AF. In the first patient, the KCG pattern of AF was mimicked by a very rapid atrial focus, whereas in the second patient, AF was due to true degeneration of the atrial activity triggered by atrial tachycardia. In both patients, the ablation of atrial focus led to the clinical disappearance of AF. The third patient had frequent episodes of AF, which lasted several days or weeks, and two documented episodes of atrial flutter. Mapping during AF showed an irregular atrial rhythm in the atrial septum, particularly in the region surrounding the coronary sinus, whereas the entire lateral right atrial free wall exhibited a constantly organized rhythm. RF energy was applied between the tricuspid ring and both the inferior vena cava and the coronary sinus, resulting in inability to reinduceatrial flutter or sustained AF. A 6-month follow-up in this patient showed the disappearance of prolonged episodes of AF.
Conclusion: The observations indicate that AF may be linked to "focal" mechanisms that can be treated by RF catheter ablation. 相似文献